Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CTSU CALGB 90601 A Randomized Doble-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab (IND #7921, NSC #704865) to Gemcitabine,


Collapse Overview 
Collapse sponsor award id
CALGB 90601


Collapse Biography 

Collapse Time 
Collapse start date
2010-09-07